| UNITED STATES |
| SECURITIES AND EXCHANGE COMMISSION |
| Washington, D.C. 20549 |
| Notice of Effectiveness |
| Effectiveness Date: |
July 1,
2025 |
| Accession Number: |
0001193125-25-153591 |
| Submission Type: |
POS AM |
| CIK: |
0001693011 |
| Company Name: |
Inozyme Pharma, Inc. |
| File Number: |
333-275364 |
|
